Follicular Challenge Test to Predict Response to GnRH Agonist Triggering
NCT ID: NCT04973969
Last Updated: 2021-07-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2021-01-01
2022-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators aim to asses the possibility to predict the respone to ovulation triggering by the response to decapeptyl in the follicular phase of the same cycle.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
GnRH Agonist Triggering Supplemented With Hcg in Women With Poor Ovarian Response
NCT02144818
Combination of Gonadotropin-releasing Hormone Agonist and Human Chorionic Gonadotropin Triggered by Normal Responder in GnRH-antagonist Cycles
NCT02862782
Ovulation Trigger With hCG Compared to GnRH Agonist in Patients With Repeated IVF Failures
NCT02048891
Human Chorionic Gonadotropin Supplementation Prior to In-vitro Fertilization Treatment in Poor Responders
NCT01205009
Follicle Size and Oocyte Development
NCT03660813
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Hormonal proflie including E2, P, LH, FSH will be measured. LH surge and the rest of the hormonal profile will be compared to day after ovulation triggering.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
study group
The participants will recieve decapeptyl 0.2 mg on day 2/3 of the follicular phase.At that day, and at the day after, hormonsl profile will be documented. The hormonal profile of the day after follicular decapeptyl administration will be compared to the hormonal profile to test the predictive value.
Decapeptyl
diagnosis of predictio value
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Decapeptyl
diagnosis of predictio value
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients planned to freeze embryos due to PGT or surrogacy --patients at high risk for OHSS
Exclusion Criteria
* known hypothalamic- pituitary dysfunction
20 Years
41 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assaf-Harofeh Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Assaf Harofeh MC
senior physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sarit Avraham, Dr
Role: PRINCIPAL_INVESTIGATOR
Asaf Harofe Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shamir medical center
Tzrifin, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Sarit Avraham, Dr
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0304-20-ASF
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.